No Time to Die’ Opens to $56M domestically but was hoped to cross $60 million.
No Time to Die, the 25th James Bond film, has been reported for duty at the North American box office with a projected opening of $56 million as Hollywood tries to rebound from the COVID-19 problem and entice older adults back to theaters.
The James Bond film, starring Daniel Craig in his farewell role as 007, easily beat off Venom: Let There Be Carnage, which made $32 million in its second weekend after opening to a pandemic-high $90 million the weekend before.
Nonetheless, MGM and EON Productions had intended for a $60 million domestic opening with No Time to Die.
The film’s debut highlights the persistent hurdles that the box office recovery is facing as studios begin to release adult-skewing films that have been delayed due to the pandemic. COVID caused No Time to Die to be postponed three times.
While superhero films like Venom 2 attract younger audiences, the Bond franchise has always been powered in large part by viewers aged 35 and up, a demographic that has been more hesitant to return to theaters.
No Time to Die managed to persuade many adults to go to the movies for the first time since COVID, but moviegoing in this sector has yet to return to pre-pandemic levels.
The Bond film had a male-dominated audience (64 percent), with 57 percent of ticket buyers over the age of 35, and 36 percent over 45. In comparison, only 9% of ticket buyers 45 and older saw Venom: Let There Be Carnage on its opening weekend.
No Time to Die, directed by Cary Fukunaga, is distributed in the United States by United Artists Releasing and internationally by Universal on behalf of MGM and EON. Along with franchise newcomers Rami Malek, Ana de Armas, and Lashana Lynch, the cast includes Lea Seydoux, Ben Whishaw, Naomie Harris, Ralph Fiennes, and Christoph Waltz.
Please check out the following website for further news articles:
